This compound is a protected D-serine derivative used as a building block in solid-phase peptide synthesis. The Fmoc group protects the amine, while the tert-butyl group protects the side-chain hydroxyl, enabling selective deprotection during chain assembly.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 128107-47-1
Fmoc-Ser(tBu)-Gly-OH
pharmaceutical intermediate
N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-4-methyl-L-leucine
pharmaceutical intermediate
Fmoc-D-Aspartic acid beta-tert-butyl ester
pharmaceutical intermediate
(S)-N-Fmoc-2-Thienylalanine
pharmaceutical intermediate
Fmoc-O-tert-butyl-D-threonine
pharmaceutical intermediate
N-Fmoc-S-(4-methoxybenzyl)-L-cysteine
pharmaceutical intermediate
Fmoc-D-leucine
pharmaceutical intermediate
3-Hydroxyazetidine-1-carboxylic acid benzyl ester
pharmaceutical intermediate
(2R)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-3-[(2-methylpropan-2-yl)oxy]propanoic acid
REITVGIIZHFVGU-LJQANCHMSA-N
CC(C)(C)OC[C@H](C(=O)O)NC(=O)OCC1C2=CC=CC=C2C3=CC=CC=C13